SynBioBeta Speaker

Zachary Gobst

Leapcure

CEO

Founder and CEO of Leapcure, the leader in patient engagement and recruitment for clinical trials. Leapcure’s equitable and empathetic service accelerates research while empowering patient advocacy. Hundreds of studies and millions of patients across more than 50 countries have used Leapcure to average 62% of study participation. Zach is also a lover of Tufte data visualization, podcasting with anyone, sleep, Fulham FC and Indiana University football (at least recently).

Sessions Featuring

Zachary

This Year

Breakout Session

•

4:30 PM

-

5:15 PM

Human Health

Rewriting the Rules - Clinical Trial Reform in the Age of AI

AI-native drug discovery is accelerating molecule design, but clinical trials remain slow, expensive, and exclusionary. If we don’t modernize trial infrastructure, we create a bottleneck between computational breakthroughs and real-world patient impact.  This breakout explores how to reform recruitment, eligibility, endpoints, biomarkers, and regulatory alignment to make U.S. trials more competitive and globally scalable.

Featuring

Mark Atalla

ONC

ONC Deputy, Policy

Andrea Bild

City of Hope

Professor & Director

Jacob Glanville

Centivax

CEO

Building a universal antivenom

Una Ryan

Ulux

Founder and CEO

Arman Sharma

HHS

Deputy CAIO

Zachary Gobst

Leapcure

CEO

Making clinical trials more equitable and accessible.

Breakout Session

•

4:30 PM

-

5:15 PM

Human Health

Rewriting the Rules - Clinical Trial Reform in the Age of AI

AI-native drug discovery is accelerating molecule design, but clinical trials remain slow, expensive, and exclusionary. If we don’t modernize trial infrastructure, we create a bottleneck between computational breakthroughs and real-world patient impact.  This breakout explores how to reform recruitment, eligibility, endpoints, biomarkers, and regulatory alignment to make U.S. trials more competitive and globally scalable.

Featuring

Mark Atalla

ONC

ONC Deputy, Policy

Andrea Bild

City of Hope

Professor & Director

Jacob Glanville

Centivax

CEO

Building a universal antivenom

Una Ryan

Ulux

Founder and CEO

Arman Sharma

HHS

Deputy CAIO

Zachary Gobst

Leapcure

CEO

Making clinical trials more equitable and accessible.

Previous Speakers Include